Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1701 results

Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK. Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK.

by Cancer Research UK | News | 15 February 2018

15 February 2018

Doctor discussing a prostate scan with a patient

An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results. An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results.

by Cancer Research UK | News | 9 February 2018

9 February 2018

Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients? Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients?

by Justine Alford | Analysis | 7 February 2018

7 February 2018

Two researchers discussing an experiment

Scientists have discovered that an amino acid called asparagine is essential for breast cancer spread. Scientists have discovered that an amino acid called asparagine is essential for breast cancer spread.

by Cancer Research UK | News | 7 February 2018

7 February 2018

We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research. We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research.

by Gabriella Beer | Analysis | 24 January 2018

24 January 2018

CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research. CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.

by Michael Walsh | Analysis | 12 January 2018

12 January 2018

Female patient talking with nurse

Our scientists have found that faults in BRCA genes don’t affect survival in young women with breast cancer, which could help inform treatment decisions. Our scientists have found that faults in BRCA genes don’t affect survival in young women with breast cancer, which could help inform treatment decisions.

by Cancer Research UK | News | 11 January 2018

11 January 2018

This entry is part 7 of 11 in the series Radiotherapy